Considering increased mouse stomach mass when calculating prophylactic vaccine efficacy against Helicobacter pylori

Helicobacter

Volumn 12, Issue 3, 2007, Pages 210-212

  Sutton, Philip ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Helicobacter pylori; Prophylatic vaccination; Stomach mass

Indexed keywords

BACTERIUM LYSATE; CHOLERA TOXIN; PHOSPHATE BUFFERED SALINE;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCULATION; COLONY FORMING UNIT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GASTRITIS; GENDER; GROUPS BY AGE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; IMMUNIZATION; INFECTION PREVENTION; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH VOLUME;

ANIMALS; BACTERIAL VACCINES; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; IMMUNIZATION; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; ORGAN SIZE; STOMACH;

HELICOBACTER PYLORI; MUS;

EID: 34247892481     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2007.00494.x     Document Type: Article

References (5)

1. Malfertheiner P, Fry LC, Monkemuller K. Can gastric cancer be prevented by Helicobacter pylori eradication? Best Pract Res Clin Gastroenterol 2006 20: 709 19.
2. Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Gastric adenocarcinoma: review and considerations for future directions. Ann Surg 2005 241: 27 39.
3. Sutton P, Doidge C. Helicobacter pylori vaccines spiral into the new millennium. Dig Liver Dis 2003 35: 675 87.
4. Ermak TH, Ding R, Ekstein B, Hill J, Myers GA, Lee CK, Pappo J, Kleanthous HK, Monath TP. Gastritis in urease-immunized mice after Helicobacter felis challenge may be due to residual bacteria. Gastroenterology 1997 113: 1118 28.
5. Sutton P, Danon SJ, Walker M, Thompson LJ, Wilson J, Kosaka T, Lee A. Post-immunisation gastritis and Helicobacter infection in the mouse: a long term study. Gut 2001 49: 467 73.